Time Is Critical
In a medical emergency, survival depends on rapid
access to life saving medicine.
Accessible Solutions
Life threatening situations outside hospital require
treatments that are practical and easy to use.
Rapid Drug Delivery
Pulmonary delivery supports rapid absorption when
every moment matters.
Our Story
Our mission is to deliver life saving medicine faster when every second counts.
We pursue innovative technologies designed to improve patient outcomes in life threatening emergencies.
Our focus is on rapid delivery, accessibility and real world use, ensuring treatment can be administered when and where it is needed most.
Professor John Fraser AO
Chief Medical Officer
Founder and Chief Medical Officer of De Motu Cordis Pty Ltd (DMC), who are developing a needle free inhaler for emergency drug delivery administration. Clinical studies are ongoing with preliminary data already available. This drug delivery platform technology under development aimsto improve outcomes and save lives in time -critical conditions. The first product DMC is developing is a needle -free dry powder inhaler of epinephrine currently under investigational testing for immediate management of anaphylaxis . He is a practising ICU doctor as well as Director of the Critical Care Research Group (CC RG) (Australia’s largest critical care research group) at The University of Queensland and Immediate Past President of the Asia Pac Extracorporeal Life Support Organisation.
Rapid delivery when time matters most
Our delivery platform is being developed to enable rapid pulmonary administration in emergency
situations where speed, accessibility and ease of use are critical.
Designed for real life
emergencies.
Medical emergencies do not happen in controlled environments. Our focus is on treatment solutions that are accessible, effective and ready when they are needed most.
We are committed to improving outcomes by bridging the gap between clinical innovation and real world application.
Partnering with De Motu Cordis
